The different manifestations of acute heart death

Hecht, A

doi:10.1016/0379-0738(80)90201-7

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…1 In adults, CAD is the cause of death in approximately 50% of cases, 1,2 with less common disease processes comprising the remainder of cases and including CM, myocarditis, and coronary artery anomalies. 4 More unusual cases of SCD reported in the literature include cardiac sarcoidosis, 5 myocardial tuberculosis, 6 isolated coronary arteritis, 7 and anomalous hypoplastic left coronary artery. 8 Another smaller, but not insignificant, subcategory of SCD involves iatrogenic deaths following therapeutic or diagnostic procedures.…”

mentioning

confidence: 99%

Iatrogenic Deaths Following Treatment for Hypertrophic Obstructive Cardiomyopathy

Batalis

Harley

Collins

2005

American Journal of Forensic Medicine &Amp; Pathology

View full text Add to dashboard Cite

Hypertrophic cardiomyopathy (HCM) is a disease process which results in a large, heavy heart, with hypertrophy of the interventricular septum (IVS) and left ventricle. HCM accounts for a significant number of cases of sudden cardiac death each year, most infamously in young athletes. The prevalence of the disease has increased over the past several years due to advances in clinical diagnosis and molecular genetic studies. Over this same period, new forms of treatment also have emerged. One such treatment is alcohol septal ablation (ASA). ASA is a procedure performed by a cardiologist, via cardiac catheterization, by injecting pure ethanol into selected arteries which supply the IVS, resulting in a targeted myocardial infarction. This infarct then retracts and forms a scar, decreasing the outflow obstruction and improving the patient's clinical symptoms.The authors report 2 cases of death following ASA treatment of HCM. The first, a 56-year-old male, had his ASA procedure 10 days prior to death. The second decedent, a 76-year-old female, had her procedure only 30 hours before death. These case reports are followed by a discussion about HCM, including pathology, treatments, and treatment-related pathology, before closing with a discussion about death certification in the cases presented and therapy-related deaths in general.

show abstract

mentioning

confidence: 99%

Iatrogenic Deaths Following Treatment for Hypertrophic Obstructive Cardiomyopathy

Batalis

Harley

Collins

2005

American Journal of Forensic Medicine &Amp; Pathology

View full text Add to dashboard Cite

show abstract

“…*Η επιτροπή έρευνας τοϋ Παγκοσμίου 'Οργανισμού 'Υ γείας (WHO), δέχτηκε ομοίως καί εισηγήθηκε τό χρονικό αυτό διάστημα τών 24 ωρών (Eliot καί Salhany, 1978). Αναλυτικό τερα οι αιφνίδιοι θάνατοι ανάλογα μέ τό χρόνο επελεύσεως τους ύποδιακρίνονται σέ "ακαριαίους" πού συμβαίνουν μέσα σέ 30 δευτερόλεπτα άπό τήν προσβολή, σέ "αναπάντεχους" πού συμ βαίνουν στίς 2 πρώτες ώρες καί τους "πρόωρους" πού συμβαί νουν ανάμεσα στίς 2-24 ώρες άπό τήν εκδήλωση τού πρώτου συμ πτώματος (Hecht, 1980, Baroldi καί συν., 1978, Κυριακίδης, . 1980) .…”

unclassified

Ιατροδικαστικη Διερευνηση Του Εμφραγματος Του Μυοκαρδιου Με Ιστοχημικη-Μακροσκοπικη Τεχνικη

Κανακησ¹

View full text Add to dashboard Cite

The different manifestations of acute heart death

Cited by 2 publications

References 0 publications

Iatrogenic Deaths Following Treatment for Hypertrophic Obstructive Cardiomyopathy

Iatrogenic Deaths Following Treatment for Hypertrophic Obstructive Cardiomyopathy

Ιατροδικαστικη Διερευνηση Του Εμφραγματος Του Μυοκαρδιου Με Ιστοχημικη-Μακροσκοπικη Τεχνικη

Contact Info

Product

Resources

About